Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
actavis
Biotech
Sarepta hires ex-Allergan leader with M&A history as CEO
Doug Ingram has become the latest person to take a turn as Sarepta Therapeutics CEO.
Nick Paul Taylor
Jun 29, 2017 5:25am
Iterum bags $65M for phase 3 trial of ex-Pfizer antibiotic
May 19, 2017 3:13am
Chutes & Ladders—Former Actavis head Bisaro to lead Impax
Mar 30, 2017 3:30pm
Chutes & Ladders: Teva CEO Vigodman steps down
Feb 9, 2017 3:30pm
Chutes & Ladders: FDA’s new drugs director to retire after Sarepta’s Exondys 51 fallout
Dec 8, 2016 4:16pm
Chutes & Ladders: Allergan CEO Saunders adds chairman to title
Oct 28, 2016 9:32am
